Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q3 2024
Institutional positions in Calidi Biotherapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −11 vs. Q2 2024
- Shares held
- 319.3K
- +51.4K (+19.2%) vs. Q2 2024Converted for a 1-for-10 split
- Total value
- $363.4K
- −$159.3K (−30.5%) vs. Q2 2024
- New holders
- 7
- 5 more added
- Sold out
- 18
- 1 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $655.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.53M |
| Q4 2023 | 25 | $2.83M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $39.0M |
| Q1 2023 | 27 | $40.6M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $205.5M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $164.7M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Householder Group Estate & Retirement Specialist, LLC | 500 | $0 | 0.00% | +500 | New |
| Bank of America Corp | 48 | $55 | 0.00% | +21+75.8% | AddedConverted for a 1-for-10 split |
| FMR LLC | 141 | $161 | 0.00% | +141 | New |
| Advisor Group Holdings, Inc. | 253 | $288 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| BlackRock, Inc. | 259 | $295 | 0.00% | +259 | New |
| CVA Family Office, LLC | 500 | $570 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| UBS Group AG | 922 | $1.05K | 0.00% | +921+92,100.0% | AddedConverted for a 1-for-10 split |
| Morgan Stanley | 2,019 | $2.30K | 0.00% | +100+5.2% | AddedConverted for a 1-for-10 split |
| Tower Research Capital LLC (TRC) | 3,671 | $4.18K | 0.00% | +2,829+335.9% | AddedConverted for a 1-for-10 split |
| 683 Capital Management, LLC | 3,788 | $4.32K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Highbridge Capital Management LLC | 6,250 | $7.13K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Evermay Wealth Management LLC | 6,342 | $7.23K | 0.00% | +6,342 | New |
| Finepoint Capital LP | 12,500 | $14.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Apollo Management Holdings, L.P. | 12,500 | $14.3K | 0.00% | +12,500 | New |
| Delta Investment Management, LLC | 21,023 | $24.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Susquehanna International Group, LLP | 23,544 | $26.8K | 0.00% | +23,544 | New |
| Geode Capital Management, LLC | 39,612 | $45.2K | 0.00% | +39,612 | New |
| Red Wave Investments LLC | 46,461 | $53.0K | 0.02% | −15,999−25.6% | ReducedConverted for a 1-for-10 split |
| CPR Investments Inc. | 56,000 | $63.8K | 0.06% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Cable Car Capital LLC | 82,937 | $94.5K | 0.10% | +81,809+7,254.5% | AddedConverted for a 1-for-10 split |
| RS Crum Inc. | 0 | $0 | 0.00% | −26,347−100.0% | Sold outConverted for a 1-for-10 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,591−100.0% | Sold outConverted for a 1-for-10 split |
| HRT Financial LP | 0 | $0 | 0.00% | −10,139−100.0% | Sold outConverted for a 1-for-10 split |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −9,470−100.0% | Sold outConverted for a 1-for-10 split |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −12,500−100.0% | Sold outConverted for a 1-for-10 split |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −6,187−100.0% | Sold outConverted for a 1-for-10 split |
| Governors Lane LP | 0 | $0 | 0.00% | −4,735−100.0% | Sold outConverted for a 1-for-10 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −4,296−100.0% | Sold outConverted for a 1-for-10 split |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −3,364−100.0% | Sold outConverted for a 1-for-10 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,597−100.0% | Sold outConverted for a 1-for-10 split |
| DLK Investment Management, LLC | 0 | $0 | 0.00% | −2,081−100.0% | Sold outConverted for a 1-for-10 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −1,494−100.0% | Sold outConverted for a 1-for-10 split |
| State Street Corp | 0 | $0 | 0.00% | −1,290−100.0% | Sold outConverted for a 1-for-10 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,113−100.0% | Sold outConverted for a 1-for-10 split |
| Financial Counselors Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| Creative Planning | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold outConverted for a 1-for-10 split |
| BlackRock Inc. | – | – | – | – | Not filed |